Author

José Antonio Encinar

Universitat de Miguel Hernández d'ElxORCID 0000-0002-7219-3863Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Camino de Juan Romero· 1 shared Elizabeth Pérez-ValencianoiD· 1 shared Laura Fuertes-García· 1 shared María Fuentes-BaileiD· 1 shared Miguel SacedaiD· 1 shared Pilar García-MoralesiD· 1 shared Salomé Araujo‐AbadiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Camino de Juan Romero

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Targeting the CDK4-Cyclin D Complex: A New Generation of Selective Kinase Inhibitors for Cancer Therapy

María Fuentes-Baile, José Antonio Encinar, Salomé Araujo‐Abad, Elizabeth Pérez-Valenciano, Pilar García-Morales, Laura Fuertes-García, Camino de Juan Romero, Miguel Saceda

This paper identifies a novel CDK4 inhibitor, diophenic, that selectively targets the CDK4-Cyclin D1 interaction, showing improved selectivity and reduced off-target effects compared to ATP-competitive inhibitors in GBM models.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology